1. Home
  2. NIC vs EVO Comparison

NIC vs EVO Comparison

Compare NIC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIC
  • EVO
  • Stock Information
  • Founded
  • NIC 2000
  • EVO 1993
  • Country
  • NIC United States
  • EVO Germany
  • Employees
  • NIC N/A
  • EVO N/A
  • Industry
  • NIC Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NIC Finance
  • EVO Health Care
  • Exchange
  • NIC Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NIC 1.6B
  • EVO 1.6B
  • IPO Year
  • NIC N/A
  • EVO 2021
  • Fundamental
  • Price
  • NIC $117.18
  • EVO $4.44
  • Analyst Decision
  • NIC Buy
  • EVO Buy
  • Analyst Count
  • NIC 4
  • EVO 2
  • Target Price
  • NIC $119.00
  • EVO $5.90
  • AVG Volume (30 Days)
  • NIC 51.4K
  • EVO 44.7K
  • Earning Date
  • NIC 04-15-2025
  • EVO 11-06-2024
  • Dividend Yield
  • NIC 0.96%
  • EVO N/A
  • EPS Growth
  • NIC 97.30
  • EVO N/A
  • EPS
  • NIC 8.05
  • EVO N/A
  • Revenue
  • NIC $346,482,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • NIC N/A
  • EVO $3.84
  • Revenue Next Year
  • NIC $3.93
  • EVO $10.94
  • P/E Ratio
  • NIC $14.54
  • EVO N/A
  • Revenue Growth
  • NIC 27.15
  • EVO N/A
  • 52 Week Low
  • NIC $75.24
  • EVO $2.85
  • 52 Week High
  • NIC $120.26
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • NIC 60.73
  • EVO 49.82
  • Support Level
  • NIC $115.96
  • EVO $4.40
  • Resistance Level
  • NIC $119.62
  • EVO $4.49
  • Average True Range (ATR)
  • NIC 2.31
  • EVO 0.10
  • MACD
  • NIC -0.03
  • EVO -0.00
  • Stochastic Oscillator
  • NIC 72.60
  • EVO 38.46

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: